Glaucoma is the second-leading cause of blindness worldwide, and is currently incurable.

ZEISS Medical Technology and Envision Health Technologies will collaborate on VR-based visual function testing to advance ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Zeiss Medical Technology has formed a strategic collaboration with digital eye health company, Envision Health Technologies, ...

David Chute, of the Treatment Accelerator Initiative, talks with OT about taking lessons from business to push innovative ...

Virtual Vision Health, a global leader in virtual reality-based ophthalmic diagnostic and patient engagement technologies, today announced significant company milestones that underscore its continued ...

As an optometrist, I see how aging affects my patients every day. Their eyes are no exception: Losing their vision, and ...

Glaucoma is often called the “silent thief of sight” for a reason. The disease can gradually damage the optic nerve for years ...

Bayer has acquired Perfuse Therapeutics, including the full rights to the PER-001 intravitreal implant, which is in development for glaucoma and diabetic retinopathy.

Aging plays a significant role in the development of conditions that can lead to blindness. However, most of these can be ...

Bayer acquired Perfuse Therapeutics and its experimental endothelin-blocking eye implant PER-001, and partnered with AI firm ...